Testing effectiveness (Phase 2)Study completedNCT00299741What this trial is testingStudy of SU11248 in Men With Advanced Prostate CancerWho this might be right forProstate Cancer Massachusetts General Hospital 36
Testing effectiveness (Phase 2)Ended earlyNCT01703065What this trial is testingCabozantinib in Men With Castration-Resistant Prostate CancerWho this might be right forAdenocarcinoma of the ProstateCastration-resistant Prostate CancerRecurrent Prostate Cancer+2 more University of Washington 9
Testing effectiveness (Phase 2)Study completedNCT01599793What this trial is testingMagnetic Resonance Imaging in Measuring the Effect of Cabozantinib in Patients With Castrate Resistant Prostate CancerWho this might be right forBone MetastasesCastrate-resistant Prostate CancerRecurrent Prostate Cancer+1 more University of Chicago 19
Large-scale testing (Phase 3)Study completedNCT00286091What this trial is testingStudy on Prolonging Bone Metastasis-Free Survival in Men With Hormone Refractory Prostate CancerWho this might be right forHormone Refractory Prostate Cancer Amgen 1,435
Testing effectiveness (Phase 2)Study completedNCT00104650What this trial is testingStudy of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) BisphosphonatesWho this might be right forBone Metastases in Men With Hormone-Refractory Prostate CancerBone Metastases in Subjects With Advanced Breast CancerBone Metastases in Subjects With Advanced Cancer or Multiple Myeloma Amgen 111
Testing effectiveness (Phase 2)Study completedNCT02463799What this trial is testingStudy of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPCWho this might be right forProstate Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 36
Large-scale testing (Phase 3)Study completedNCT00950911What this trial is testingOpen Label Extension to SRE Studies in United Kingdom and Czech Republic OnlyWho this might be right forBone Metastases in Men With Hormone-Refractory Prostate CancerBone Metastases in Subjects With Advanced Breast CancerBone Metastases in Subjects With Advanced Cancer or Multiple Myeloma Amgen 35
Early research (Phase 1)Study completedNCT01347788What this trial is testingCabozantinib (XL184) in Men With Castrate-Resistant Prostate CancerWho this might be right forProstate Adenocarcinoma Massachusetts General Hospital 34
Testing effectiveness (Phase 2)Study completedNCT00936975What this trial is testingFluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone MetastasesWho this might be right forHormone-Resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneRecurrent Prostate Carcinoma+1 more National Cancer Institute (NCI) 18
Large-scale testing (Phase 3)Study completedNCT01419717What this trial is testingOpen-Label Access Protocol of Denosumab for Subjects With Advanced CancerWho this might be right forBone Metastases in Men With Hormone-Refractory Prostate CancerBone Metastases in Subjects With Advanced Breast Cancer Amgen 129
Large-scale testing (Phase 3)WithdrawnNCT00691899What this trial is testingAssess the Effects of MK0822 in Prolonging Time to First Bone Metastasis in Men With Castration-Resistant Prostate Cancer (0822-030)Who this might be right forProstate Cancer Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)Active Not RecruitingNCT03317392What this trial is testingTesting the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone MetastasisWho this might be right forCastration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8 National Cancer Institute (NCI) 132
Testing effectiveness (Phase 2)Study completedNCT03204812What this trial is testingDurvalumab and Tremelimumab in Treating Chemotherapy Naive Patients With Metastatic Castration-Resistant Prostate CancerWho this might be right forCastration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneProstate Adenocarcinoma+3 more M.D. Anderson Cancer Center 31
Large-scale testing (Phase 3)Study completedNCT00321620What this trial is testingStudy of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate CancerWho this might be right forBone Metastases Amgen 1,904
Testing effectiveness (Phase 2)Ended earlyNCT00753220What this trial is testingSafety Study of Autologous Dendritic Cells Injected Into the Prostate After Cryoablation for Advanced Prostate CancerWho this might be right forProstate Cancer Bostwick Laboratories 7
Not applicableEnded earlyNCT05301062What this trial is testingA Research Called CREDIT Studies How Safe the Study Treatment Radium-223 is and How Well it Works in Chinese Men With Advanced Prostate Cancer That Has Spread to the Bones and Does Not Respond to Treatments for Lowering Testosterone LevelsWho this might be right forMetastatic Castration-resistant Prostate CancerBone Metastases Bayer 8
Not applicableStudy completedNCT01062503What this trial is testingDuration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic CRPCWho this might be right forMetastatic Prostate CancerBone Metastasis University Health Network, Toronto 48
Large-scale testing (Phase 3)Study completedNCT02043678What this trial is testingRadium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild SymptomsWho this might be right forProstatic Neoplasms Bayer 806
Large-scale testing (Phase 3)Study completedNCT01824342What this trial is testingDenosumab for Prolonging Bone Metastasis-Free Survival in Men With Hormone-Refractory Prostate CancerWho this might be right forCastrate-resistant Prostate Cancer Amgen 18